Regulation of Apoptosis is Impaired in Atrophic Gastritis Associated with Gastric Cancer

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2017 Jul 1

PMID 28662697

Citations 8

Authors

R Rosania

M Varbanova

T Wex

C Langner

J Bornschein

F Giorgio

E Ierardi

P Malfertheiner

Affiliations

Soon will be listed here.

Abstract

Background: Gastric premalignant conditions, atrophic gastritis (AG) and intestinal metaplasia (IM) are characterized by an increase of proliferation and a reduction of apoptosis in epithelial cells. The epithelial cell kinetics in AG and IM in gastric mucosa adjacent to gastric cancer is still unclear. The aim of this study was to evaluate the epithelial cell turnover and expression of proliferation and apoptosis-related genes in gastric cancer (GC) and adjacent mucosa with atrophic gastritis or intestinal metaplasia (AG/IM GC+), as well as in atrophic gastritis or intestinal metaplasia mucosa of patients without GC (AG/IM GC-) and in control biopsy samples of non-transformed gastric mucosa (Control).

Methods: We selected 58 patients (M: F = 34:24; age range 20-84 years, median 61.06 years) with 4 well defined histological conditions: 20 controls with histological finding of non-transformed gastric mucosa, 20 patients with AG or IM (AG/IM GC-), and 18 patients with intestinal type gastric adenocarcinoma (GC) and AG or IM in the adjacent mucosa (3 cm from the macroscopic tumour margin, AG/IM GC+). We performed an immunohistochemical staining of Ki67 and TUNEL and quantitative RT-PCR to determine the expression of PCNA and Bax/Bcl-2.

Results: The immunohistochemical expression of Ki67 and TUNEL in AG/IM GC- was significantly increased compared to not transformed gastric mucosa (p < 0.0001) but not compared to AG/IM in gastric mucosa adjacent to GC. Levels of Bcl-2 were reduced in GC and AG/IM GC- compared to controls as well as in AG/IM GC- compared to AG/IM in mucosa adjacent to GC+ (p < 0.05). Proliferation and apoptosis markers did not correlate with H.pylori status in our study population.

Conclusions: In AG/IM associated with GC, no significant changes in the epithelial cell turnover were detected. Decreased Bcl-2 gene expression signified atrophic gastritis and IM in presence of cancer, as well as intestinal type gastric adenocarcinoma.

Citing Articles

Natural products based on Correa's cascade for the treatment of gastric cancer trilogy: Current status and future perspective.

Liao W, Wang J, Li Y J Pharm Anal. 2025; 15(2):101075.

PMID: 39957902 PMC: 11830317. DOI: 10.1016/j.jpha.2024.101075.

Programmed cell death in infection and related gastric cancer.

Lin Y, Liu K, Lu F, Zhai C, Cheng F Front Cell Infect Microbiol. 2024; 14:1416819.

PMID: 39145306 PMC: 11322058. DOI: 10.3389/fcimb.2024.1416819.

Progress in traditional Chinese medicine against chronic gastritis: From chronic non-atrophic gastritis to gastric precancerous lesions.

Yang L, Liu X, Zhu J, Zhang X, Li Y, Chen J Heliyon. 2023; 9(6):e16764.

PMID: 37313135 PMC: 10258419. DOI: 10.1016/j.heliyon.2023.e16764.

Fermented kimchi rejuvenated precancerous atrophic gastritis via mitigating -associated endoplasmic reticulum and oxidative stress.

Park J, Han Y, Oh J, Lee D, Choi S, Kim S J Clin Biochem Nutr. 2021; 69(2):158-170.

PMID: 34616108 PMC: 8482386. DOI: 10.3164/jcbn.20-180.

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism.

Tong Y, Liu L, Wang R, Yang T, Wen J, Wei S Front Pharmacol. 2021; 12:644638.

PMID: 33841162 PMC: 8026873. DOI: 10.3389/fphar.2021.644638.

References

Ierardi E, Francavilla R, Panella C . Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation. Ital J Gastroenterol Hepatol. 1998; 29(5):470-5. View

Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer S . BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991; 88(16):6961-5. PMC: 52213. DOI: 10.1073/pnas.88.16.6961. View

Anagnostopoulos G, Stefanou D, Arkoumani E, Sakorafas G, Pavlakis G, Arvanitidis D . Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study. J Gastroenterol Hepatol. 2005; 20(11):1674-8. DOI: 10.1111/j.1440-1746.2005.04057.x. View

Cahill R, OMorain C . Gastric epithelial cell proliferation. Eur J Cancer Prev. 1994; 3 Suppl 2:55-60. DOI: 10.1097/00008469-199412002-00010. View

Barrezueta L, Oshima C, Lima F, de Oliveira Costa H, Gomes T, Neto R . The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Rep. 2011; 3(2):261-7. DOI: 10.3892/mmr_00000249. View

Fan X, Kelleher D, Fan X, Xia H, Keeling P . Helicobacter pylori increases proliferation of gastric epithelial cells. Gut. 1996; 38(1):19-22. PMC: 1382973. DOI: 10.1136/gut.38.1.19. View

Nakanishi H, Ohsawa M, Naka N, Uchida A, Ochi T, Aozasa K . Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis. Oncology. 1997; 54(3):238-44. DOI: 10.1159/000227695. View

Wex T, Treiber G, Lendeckel U, Malfertheiner P . A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin Chem Lab Med. 2003; 41(8):1033-7. DOI: 10.1515/CCLM.2003.159. View

Maga G, Hubscher U . Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003; 116(Pt 15):3051-60. DOI: 10.1242/jcs.00653. View

10.

Cory S, Huang D, Adams J . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22(53):8590-607. DOI: 10.1038/sj.onc.1207102. View

11.

Murakami K, Fujioka T, Kodama R, Kubota T, TOKIEDA M, Nasu M . Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol. 1997; 32(2):184-8. DOI: 10.1007/BF02936365. View

12.

Pietenpol J, Papadopoulos N, Markowitz S, WILLSON J, Kinzler K, Vogelstein B . Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res. 1994; 54(14):3714-7. View

13.

Erkan G, Gonul I, Kandilci U, Dursun A . Evaluation of apoptosis along with BCL-2 and Ki-67 expression in patients with intestinal metaplasia. Pathol Res Pract. 2012; 208(2):89-93. DOI: 10.1016/j.prp.2011.12.002. View

14.

Que F, Gores G . Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology. 1996; 110(4):1238-43. DOI: 10.1053/gast.1996.v110.pm8613014. View

15.

Dixon M, Genta R, Yardley J, Correa P . Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20(10):1161-81. DOI: 10.1097/00000478-199610000-00001. View

16.

Triantafyllou K, Kitsanta P, Karamanolis D, Kittas C, Ladas S . Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population. Dig Liver Dis. 2007; 40(1):39-45. DOI: 10.1016/j.dld.2007.09.010. View

17.

Lauwers G, SCOTT G, Karpeh M . Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer. 1995; 75(9):2209-13. DOI: 10.1002/1097-0142(19950501)75:9<2209::aid-cncr2820750904>3.0.co;2-m. View

18.

Marzo I, Brenner C, Zamzami N, Jurgensmeier J, Susin S, Vieira H . Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 1998; 281(5385):2027-31. DOI: 10.1126/science.281.5385.2027. View

19.

Nardone G, Staibano S, Rocco A, Mezza E, DArmiento F, Insabato L . Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut. 1999; 44(6):789-99. PMC: 1727537. DOI: 10.1136/gut.44.6.789. View

20.

Krajewska M, Fenoglio-Preiser C, Krajewski S, Song K, Macdonald J, Stemmerman G . Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol. 1996; 149(5):1449-57. PMC: 1865280. View